drug

zilebesiran

Status: Investigational
Code: ALN-AGT01
Trials: 2 registered trials in coverage

Relationships

Targets Angiotensinogen

Treats Hypertension

Developed by Alnylam Pharmaceuticals

Developed by Roche

Timeline

No published stories yet.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.